(E)-N-[(5-nitrofuran-2-yl)methylidene]hydroxylamine - CAS 555-15-7
Catalog: |
BB029075 |
Product Name: |
(E)-N-[(5-nitrofuran-2-yl)methylidene]hydroxylamine |
CAS: |
555-15-7 |
Synonyms: |
(2E)-5-nitro-2-furancarboxaldehyde oxime; (NE)-N-[(5-nitrofuran-2-yl)methylidene]hydroxylamine |
IUPAC Name: | (NE)-N-[(5-nitrofuran-2-yl)methylidene]hydroxylamine |
Description: | (E)-N-[(5-nitrofuran-2-yl)methylidene]hydroxylamine (CAS# 555-15-7) is a carcinogenic and mutagenic compound. |
Molecular Weight: | 156.10 |
Molecular Formula: | C5H4N2O4 |
Canonical SMILES: | C1=C(OC(=C1)[N+](=O)[O-])C=NO |
InChI: | InChI=1S/C5H4N2O4/c8-6-3-4-1-2-5(11-4)7(9)10/h1-3,8H/b6-3+ |
InChI Key: | PTBKFATYSVLSSD-ZZXKWVIFSA-N |
Boiling Point: | 274.8 °C at 760 mmHg |
Density: | 1.58 g/cm3 |
MDL: | MFCD00003226 |
LogP: | 1.51910 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021202816-A1 | Broad-spectrum antiviral peptides | 20200331 |
US-10980756-B1 | Methods of treatment | 20200316 |
WO-2021188564-A1 | Methods of treating covid-19 with a niclosamide compound | 20200316 |
WO-2021163620-A1 | Peptide compositions and methods of use thereof | 20200214 |
WO-2021160049-A1 | Bacteriostatic composition, preparation method therefor and use thereof | 20200212 |
PMID | Publication Date | Title | Journal |
16107157 | 20050825 | Design and synthesis of a series of melamine-based nitroheterocycles with activity against Trypanosomatid parasites | Journal of medicinal chemistry |
15857133 | 20050505 | Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk) | Journal of medicinal chemistry |
14642910 | 20031001 | Sequential-injection stripping analysis of nifuroxime using DNA-modified glassy carbon electrodes | Bioelectrochemistry (Amsterdam, Netherlands) |
11448232 | 20010719 | ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds | Journal of medicinal chemistry |
10571254 | 19991201 | Nitrofuran drugs as common subversive substrates of Trypanosoma cruzi lipoamide dehydrogenase and trypanothione reductase | Biochemical pharmacology |
Complexity: | 176 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 1 |
Exact Mass: | 156.01710661 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 5 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 156.01710661 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 91.6 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.3 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Furans
Customers Also Viewed
-
[132182-92-4]
Pentane, 1,1,1,2,2,3,4,5,5,5-decafluoro-3-methoxy-4-(trifluoromethyl)-
-
[55408-10-1]
Ethyl Tetrazole-5-carboxylate
-
[75726-96-4]
2-Bromo-N-isopropylacetamide
-
[37793-53-6]
N10-(Trifluoroacetyl)pteroic acid
-
[1808-26-0]
Ethyl arachidonate
-
[4294-16-0]
N6-Benzyl Adenosine
INDUSTRY LEADERS TRUST OUR PRODUCTS